Jiangsu Hengrui Medicine
600276.SS
$11.56
Share price
3.83%
Change (1 day)
22.47%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
Jiangsu Hengrui Medicine (600276.SS) - Cash on Hand
Cash on Hand as of September 2024 : NZ$5.67 Billion
According to Jiangsu Hengrui Medicine
's latest financial reports the company has NZ$5.67 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Jiangsu Hengrui Medicine - Cash on Hand chart (from 2000 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | NZ$4.08 B | -5.12% |
| 2021-12-31 | NZ$4.30 B | 23.18% |
| 2020-12-31 | NZ$3.49 B | 21.12% |
| 2019-12-31 | NZ$2.88 B | 19.17% |
| 2018-12-31 | NZ$2.41 B | 161.94% |
| 2017-12-31 | NZ$0.92 B | -9.57% |
| 2016-12-31 | NZ$1.02 B | -11.75% |
| 2015-12-31 | NZ$1.15 B | 62.78% |
| 2014-12-31 | NZ$0.71 B | 62.99% |
| 2013-12-31 | NZ$0.43 B | 68.27% |
| 2012-12-31 | NZ$0.25 B | 33.92% |
| 2011-12-31 | NZ$0.19 B | -0.77% |
| 2010-12-31 | NZ$0.19 B | 36.83% |
| 2009-12-31 | NZ$0.14 B | 21.16% |
| 2008-12-31 | NZ$0.11 B | -22.08% |
| 2007-12-31 | NZ$0.15 B | 44.03% |
| 2006-12-31 | NZ$0.10 B | 34% |
| 2005-12-31 | NZ$78.23 M | 26.96% |
| 2004-12-31 | NZ$61.62 M | 64.68% |
| 2003-12-31 | NZ$37.41 M | -15.31% |
| 2002-12-31 | NZ$44.18 M | -43.96% |
| 2001-12-31 | NZ$78.84 M | -40.2% |
| 2000-12-31 | NZ$0.13 B | 488.25% |
| 1999-12-31 | NZ$22.41 M | 249.59% |
| 1998-12-31 | NZ$6.41 M | 19.66% |
| 1997-12-31 | NZ$5.35 M |